[Progressive multifocal leukoencephalopathy]

Area of Science:

• Neurovirology
• Immunology
• Neurology

Background:

• Progressive multifocal leukoencephalopathy (PML) is a rare but serious opportunistic infection of the brain.
• It is caused by the JC polyomavirus (JCPyV), typically in immunocompromised individuals.
• The incidence of PML has risen due to its association with certain biologic therapies, including natalizumab for multiple sclerosis.

Purpose of the Study:

• To provide a comprehensive overview of the biology and pathogenesis of PML.
• To highlight the importance of cerebrospinal fluid (CSF) diagnostics in PML detection.
• To discuss current PML case definitions, risk management, and therapeutic options.

Main Methods:

• Review of published literature on JC polyomavirus and PML.
• Analysis of diagnostic approaches, particularly CSF analysis.
• Synthesis of current recommendations for risk management, therapy, and prevention.

Main Results:

• JCPyV infects oligodendrocytes, leading to demyelination in PML.
• CSF analysis is crucial for accurate and timely PML diagnosis.
• Risk stratification and monitoring are essential for patients on immunosuppressive therapies.

Conclusions:

• Understanding PML pathogenesis is key to developing effective treatments.
• Early diagnosis via CSF testing improves patient outcomes.
• Multidisciplinary management strategies are necessary for PML prevention and treatment.